Global Advanced Therapy Medicinal Products Market size was valued at USD 12.96 Bn. in 2023 and the total Advanced Therapy Medicinal Products revenue is expected to grow by 13.2 % from 2024 to 2030, reaching nearly USD 30.87 Bn.Advanced Therapy Medicinal Products Market Overview:
ATMPs (advanced therapeutic medical products) are medicines of human that are based on the genetic, tissue makeup of human beings. It provides the whole new avenues for the treatment of sicknesses which are rare and critical injuries. Medical products in advanced treatment are progressive therapies that rely on high-quality treatment, extensive cell treatment, and tissue-constructed things. As a consequence, the worldwide advanced treatment medical goods market is projected to grow during the forecast period. ATMPs are pharmaceuticals that act on live cells or dynamic hereditary materials to provide innovative therapeutic options for a variety of infections, both acute and chronic.To know about the Research Methodology :- Request Free Sample Report
Advanced Therapy Medicinal Products Market Dynamics:
A Booming Industry Driven by Innovation and Investment The introduction of Advanced Therapy Medicinal Products (ATMPs) has changed the pharmaceutical business and the panorama of medical treatment. It has laid the foundation for novel treatments for incurable illnesses and cancers of different kinds. The market is being driven by the success of products like Kymriah, Zolgensma, and others. The COVID-19 pandemic has driven a significant increase in the use of innovative treatments in virology research. T-cell therapy has the potential to cure high-risk COVID-19-infected patients, as mentioned in research published in December 2020. Before this, the FDA in the United States authorized ALVR109 (an allogeneic T-cell therapy IND application) for the treatment of COVID-19 patients in September 2020. This is likely to propel expenditure in advanced treatment research and development for SARS-CoV2 infections. Furthermore, an increasing number of clinical trials including Mesenchymal Stromal/Stem Cells (MSCs) have recently been filed as a novel therapy paradigm for SARS-CoV-2 infection. These treatments have exhibited encouraging outcomes in research programs as a therapeutic method, contributing to the marketspace's organic revenue creation which boosts the Cell Therapy Treatments Market. The market for advanced treatment medical products has risen exponentially in recent years. This industry is expected to become more competitive as a growing number of businesses enter the market. Furthermore, new Advanced Therapy Medicinal Products (ATMP) approvals have boosted this sector's growth. Market participants are employing a variety of methods in order to maintain their market position. The current trend in this sector is collaborations with contract manufacturing firms. Due to increased Research and Development activity in this sector, contract manufacturing organizations (CMOs) are seeing a surge in demand for their services. Moreover, tie-ups with Contract research organizations and contract manufacturing organizations are economical, licensed, and offer safety and security towards the end product. Hence, this factor is likely to motivate Advanced Therapy Medicinal Products Market growth in the future. Gene Therapy Products Market Poised for Growth as Protein and Small Molecule-Based Research Intensifies Various protein and small molecule-based research and design firms have begun to focus on adoptive cell T treatments. For example, the U.S. FDA approved Bristol Myers Squibb's Abecma (idecabtagene vicleucel) - a cell-based gene therapy medicinal product designed for the treatment of patients with multiple myeloma in March 2021, through a partnership with Bluebird-Bio. As a result, the demand for the Gene Therapy Products Market is increasing. Investments in Advanced Therapy Medicinal Products and an increase in financing is expected to deliver plenty of growth opportunities in the market. T-cell therapies are supported financially by grants awarded to university hospitals. Some market players have undertaken in-house production of therapies, and several players prefer service from third-party providers, including contract manufacturing organizations. On the other side, numerous companies have marked their presence in the market just by obtaining small and emerging CAR T-cell therapy developers. Some notable and recent examples include the purchases of Kite Pharma by Gilead Life Science, AveXis by Novartis, and Juno Therapeutics by Celgene. Therefore, the factors above boost the market growth.Advanced Therapy Medicinal Products Market Segment Analysis
Based on the Therapy Type, The tissue-engineered product segment is anticipated to adhere to the growth of the Advanced Therapy Medicinal Products Market. The tissue-engineered product category led the market accounting for 39.0% of revenue share. The adoption of tissue-engineered products or processes as an important element of medicine and treatment procedures, particularly in therapies that demand functional recovery of any sick or wounded area of the body, may be ascribed to this dominance. The amount of publications, research papers, clinical trials, and translational products has increased dramatically in recent years, indicating that this area has gained substantial popularity which has propelled the Tissue Engineered Products Market. Furthermore, the segment's expansion is aided by ongoing advances in technology and products to advance the tissue engineering process. For example, a group of researchers at the University of Illinois Chicago presented a unique hydrogel-shaped-changing 4D material in February 2021 that can change form in response to physiological inputs. The CAR-T treatment sector, on the other hand, is getting popular in the market and is anticipated to grow at the strongest rate throughout the projection period. Key firms including Novartis AG, Gilead Sciences, Inc., and Bristol-Myers Squibb are emphasizing increasing the global reach of their CAR-T therapies which increases the demand for the CAR-T Cell Therapies Market. For example, Novartis AG revealed that the Health Sciences Authority has authorized Kymriah as Singapore's first commercially licensed CAR-T treatment. It is expected that the growth by other segments such as cell therapy which is segmented into two different sub-segments i.e. stem cell therapy and non-stem cell therapy. Stem cell therapy promotes the healing response of diseased, injured tissue using stem cells and due to this Stem Cell-based Therapies Market is in demand. There are physical therapy, occupational therapy, speech therapy, and other types of rehabilitation that come under neurological disorder therapies which increases the demand for the neurological disorder therapies market.Advanced Therapy Medicinal Products Market Share(%), By Therapy Type (2023)
Advanced Therapy Medicinal Products Market Share(%), By Therapy Type, By Cell Therapy(2023)
Based on the Distribution Channel, Hospital Pharmacies dominated the market in the year 2023 with almost 53% in terms of revenue share and is expected to dominate the ATMP market during the forecast period. Other segments such as retail pharmacies and online pharmacies are gaining some popularity in the market. The expansion of Retail pharmacies is expected throughout the forecast period, particularly for less complex products. Online pharmacies are leveraging and increasing its demand, as the convenience and accessibility to reach patients in remote areas is also increasing. As a result, the demand for the Advanced Therapy Medicinal Products(ATMP) Industry and Advanced Therapy Clinical Trials Market as well.
Advanced Therapy Medicinal Products Market Regional Insights:
North American region dominated the market in the year 2023 and is estimated to hit the market growth of the Advanced Therapy Medical Products Market with 49% of revenue share in the year 2023. The region's dominance in the market for advanced treatment medical goods is due to a favorable regulatory environment, successful product launches, and significant expenditures in research and development. Furthermore, the fast-growing majority of clinical investigations in this novel therapeutic method in the United States contribute to regional growth. In March 2021, the United States contributed around 57.0% of all the current immunotherapy trials worldwide. This high share implies that the market is seeing an increase in investment, which is driving revenue creation and can boost the Rare Disease Therapies Market. The Asia-Pacific region is expected to reach a CAGR of over 9% during the forecast period. Countries including Japan, China, and South Korea are leading in the recent global growth of the Asia-Pacific for the ATMP market as the manufacturing of these products increases the demand for the ATMP Manufacturing Processes Market. Due to a robust research basis for innovative treatments, Europe held the second-largest share of the market in 2023. Further, the presence of prominent players in the regions is estimated to fuel the market growth in the forecast period.Advanced Therapy Medicinal Products Market Share(%), By Region in 2022
The objective of the report is to present a comprehensive analysis of the Advanced Therapy Medicinal Products Market including all the stakeholders of the End User. The past and current status of the End User with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the End User with a dedicated study of key players that includes market leaders, followers, and new entrants by region. PORTER, SVOR, and PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the End User to the decision-makers. The report also helps in understanding the Market dynamics, and structure by analyzing the market segments and projecting the Advanced Therapy Medicinal Products Market size. Clear representation of competitive analysis of key players by type, price, financial position, Derivatives portfolio, growth strategies, and regional presence in the Advanced Therapy Medicinal Products Market makes the report an investor’s guide.
Advanced Therapy Medicinal Products Market Scope: Inquire before buying
Advanced Therapy Medicinal Products Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 12.96 Bn. Forecast Period 2024 to 2030 CAGR: 13.2% Market Size in 2030: US $ 30.87 Bn. Segments Covered: by Therapy Type Cell Therapy Stem Cell Therapy Non-stem Cell Therapy CAR-T Therapy Gene Therapy Tissue Engineered Product by Disease Type Alzheimer’s Cystic Fibrosis Muscular Dystrophies Hemophilia by Distribution Channel Hospital Pharmacy Retail Pharmacy Online Pharmacy Advanced Therapy Medicinal Products Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Advanced Therapy Medicinal Products Market Key Players
1. Spark Therapeutics, Inc [United States] 2. Bluebird Bio, Inc. 3. Novartis AG 4. UniQure N.V. 5. Celgene Corporation [United States] 6. Gilead Lifesciences, Inc. 7. Kolon TissueGene, Inc. 8. JCR Pharmaceuticals Co., Ltd. 9. MEDIPOST; 10. Vericel Corporation; 11. PHARMICELL Co., Ltd 12. Organogenesis Inc. 13. ViaCyte 14. Magenta Therapeutics 15. ReNeuron 16. Promethera Biosciences 17. Fate Therapeutics 18. Century Therapeutics Frequently Asked Questions: 1] What segments are covered in the Global Advanced Therapy Medicinal Products Market report? Ans. The segments covered in the Advanced Therapy Medicinal Products Market report are based on Therapy Type, Disease Type, and Distribution Channel, and Region. 2] Which region is expected to hold the highest share of the Global Advanced Therapy Medicinal Products Market? Ans. The North American region is expected to hold the highest share of the Advanced Therapy Medicinal Products Market. The United States is expected to lead the North American market and is expected to grow at a CAGR of 8.2% over the forecast period. 3] What is the market size of the Global Advanced Therapy Medicinal Products Market by 2030? Ans. The market size of the Advanced Therapy Medicinal Products Market by 2030 is expected to reach US$ 30.87 Bn. 4] What is the forecast period for the Global Advanced Therapy Medicinal Products Market? Ans. The forecast period for the Advanced Therapy Medicinal Products Market is 2024-2030 5] What was the market size of the Global Advanced Therapy Medicinal Products Market in 2023? Ans. The market size of the Advanced Therapy Medicinal Products Market in 2023 was valued at US$ 12.96 Bn.
1. Advanced Therapy Medicinal Products Market: Research Methodology 2. Advanced Therapy Medicinal Products Market Introduction 2.1. Study Assumption and Market Definition 2.2. Scope of the Study 2.3. Executive Summary 3. Advanced Therapy Medicinal Products Market: Dynamics 3.1. Advanced Therapy Medicinal Products Market Trends by Region 3.1.1. North America Advanced Therapy Medicinal Products Market Trends 3.1.2. Europe Advanced Therapy Medicinal Products Market Trends 3.1.3. Asia Pacific Advanced Therapy Medicinal Products Market Trends 3.1.4. Middle East and Africa Advanced Therapy Medicinal Products Market Trends 3.1.5. South America Advanced Therapy Medicinal Products Market Trends 3.2. Advanced Therapy Medicinal Products Market Dynamics by Region 3.2.1. North America 3.2.1.1. North America Advanced Therapy Medicinal Products Market Drivers 3.2.1.2. North America Advanced Therapy Medicinal Products Market Restraints 3.2.1.3. North America Advanced Therapy Medicinal Products Market Opportunities 3.2.1.4. North America Advanced Therapy Medicinal Products Market Challenges 3.2.2. Europe 3.2.2.1. Europe Advanced Therapy Medicinal Products Market Drivers 3.2.2.2. Europe Advanced Therapy Medicinal Products Market Restraints 3.2.2.3. Europe Advanced Therapy Medicinal Products Market Opportunities 3.2.2.4. Europe Advanced Therapy Medicinal Products Market Challenges 3.2.3. Asia Pacific 3.2.3.1. Asia Pacific Advanced Therapy Medicinal Products Market Drivers 3.2.3.2. Asia Pacific Advanced Therapy Medicinal Products Market Restraints 3.2.3.3. Asia Pacific Advanced Therapy Medicinal Products Market Opportunities 3.2.3.4. Asia Pacific Advanced Therapy Medicinal Products Market Challenges 3.2.4. Middle East and Africa 3.2.4.1. Middle East and Africa Advanced Therapy Medicinal Products Market Drivers 3.2.4.2. Middle East and Africa Advanced Therapy Medicinal Products Market Restraints 3.2.4.3. Middle East and Africa Advanced Therapy Medicinal Products Market Opportunities 3.2.4.4. Middle East and Africa Advanced Therapy Medicinal Products Market Challenges 3.2.5. South America 3.2.5.1. South America Advanced Therapy Medicinal Products Market Drivers 3.2.5.2. South America Advanced Therapy Medicinal Products Market Restraints 3.2.5.3. South America Advanced Therapy Medicinal Products Market Opportunities 3.2.5.4. South America Advanced Therapy Medicinal Products Market Challenges 3.3. PORTER’s Five Forces Analysis 3.4. PESTLE Analysis 3.5. Technology Roadmap 3.6. Regulatory Landscape by Region 3.6.1. North America 3.6.2. Europe 3.6.3. Asia Pacific 3.6.4. Middle East and Africa 3.6.5. South America 3.7. Key Opinion Leader Analysis For Advanced Therapy Medicinal Products Market 3.8. Analysis of Government Schemes and Initiatives For the Advanced Therapy Medicinal Products Market 3.9. The Global Pandemic Impact on the Advanced Therapy Medicinal Products Market 4. Advanced Therapy Medicinal Products Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million and Volume in Units) (2023-2030) 4.1. Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 4.1.1. Cell Therapy 4.1.1.1. Stem Cell Therapy 4.1.1.2. Non-stem Cell Therapy 4.1.2. CAR-T Therapy 4.1.3. Gene Therapy 4.1.4. Tissue Engineered Product 4.2. Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 4.2.1. Alzheimer’s 4.2.2. Cystic Fibrosis 4.2.3. Muscular Dystrophies 4.2.4. Hemophilia 4.3. Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 4.3.1. Hospital Pharmacy 4.3.2. Retail Pharmacy 4.3.3. Online Pharmacy 4.4. Advanced Therapy Medicinal Products Market Size and Forecast, by Region (2023-2030) 4.4.1. North America 4.4.2. Europe 4.4.3. Asia Pacific 4.4.4. Middle East and Africa 4.4.5. South America 5. North America Advanced Therapy Medicinal Products Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million and Volume in Units) (2023-2030) 5.1. North America Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 5.1.1. Cell Therapy 5.1.1.1. Stem Cell Therapy 5.1.1.2. Non-stem Cell Therapy 5.1.2. CAR-T Therapy 5.1.3. Gene Therapy 5.1.4. Tissue Engineered Product 5.2. North America Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 5.2.1. Alzheimer’s 5.2.2. Cystic Fibrosis 5.2.3. Muscular Dystrophies 5.2.4. Hemophilia 5.3. North America Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 5.3.1. Hospital Pharmacy 5.3.2. Retail Pharmacy 5.3.3. Online Pharmacy 5.4. North America Advanced Therapy Medicinal Products Market Size and Forecast, by Country (2023-2030) 5.4.1. United States 5.4.1.1. United States Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 5.4.1.1.1. Cell Therapy 5.4.1.1.1.1. Stem Cell Therapy 5.4.1.1.1.2. Non-stem Cell Therapy 5.4.1.1.2. CAR-T Therapy 5.4.1.1.3. Gene Therapy 5.4.1.1.4. Tissue Engineered Product 5.4.1.2. United States Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 5.4.1.2.1. Alzheimer’s 5.4.1.2.2. Cystic Fibrosis 5.4.1.2.3. Muscular Dystrophies 5.4.1.2.4. Hemophilia 5.4.1.3. United States Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 5.4.1.3.1. Hospital Pharmacy 5.4.1.3.2. Retail Pharmacy 5.4.1.3.3. Online Pharmacy 5.4.2. Canada 5.4.2.1. Canada Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 5.4.2.1.1. Cell Therapy 5.4.2.1.1.1. Stem Cell Therapy 5.4.2.1.1.2. Non-stem Cell Therapy 5.4.2.1.2. CAR-T Therapy 5.4.2.1.3. Gene Therapy 5.4.2.1.4. Tissue Engineered Product 5.4.2.2. Canada Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 5.4.2.2.1. Alzheimer’s 5.4.2.2.2. Cystic Fibrosis 5.4.2.2.3. Muscular Dystrophies 5.4.2.2.4. Hemophilia 5.4.2.3. Canada Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 5.4.2.3.1. Hospital Pharmacy 5.4.2.3.2. Retail Pharmacy 5.4.2.3.3. Online Pharmacy 5.4.3. Mexico 5.4.3.1. Mexico Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 5.4.3.1.1. Cell Therapy 5.4.3.1.1.1. Stem Cell Therapy 5.4.3.1.1.2. Non-stem Cell Therapy 5.4.3.1.2. CAR-T Therapy 5.4.3.1.3. Gene Therapy 5.4.3.1.4. Tissue Engineered Product 5.4.3.2. Mexico Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 5.4.3.2.1. Alzheimer’s 5.4.3.2.2. Cystic Fibrosis 5.4.3.2.3. Muscular Dystrophies 5.4.3.2.4. Hemophilia 5.4.3.3. Mexico Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 5.4.3.3.1. Hospital Pharmacy 5.4.3.3.2. Retail Pharmacy 5.4.3.3.3. Online Pharmacy 6. Europe Advanced Therapy Medicinal Products Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million and Volume in Units) (2023-2030) 6.1. Europe Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 6.2. Europe Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 6.3. Europe Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 6.4. Europe Advanced Therapy Medicinal Products Market Size and Forecast, by Country (2023-2030) 6.4.1. United Kingdom 6.4.1.1. United Kingdom Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 6.4.1.2. United Kingdom Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 6.4.1.3. United Kingdom Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 6.4.2. France 6.4.2.1. France Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 6.4.2.2. France Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 6.4.2.3. France Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 6.4.3. Germany 6.4.3.1. Germany Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 6.4.3.2. Germany Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 6.4.3.3. Germany Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 6.4.4. Italy 6.4.4.1. Italy Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 6.4.4.2. Italy Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 6.4.4.3. Italy Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 6.4.5. Spain 6.4.5.1. Spain Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 6.4.5.2. Spain Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 6.4.5.3. Spain Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 6.4.6. Sweden 6.4.6.1. Sweden Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 6.4.6.2. Sweden Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 6.4.6.3. Sweden Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 6.4.7. Austria 6.4.7.1. Austria Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 6.4.7.2. Austria Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 6.4.7.3. Austria Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 6.4.8. Rest of Europe 6.4.8.1. Rest of Europe Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 6.4.8.2. Rest of Europe Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 6.4.8.3. Rest of Europe Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 7. Asia Pacific Advanced Therapy Medicinal Products Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million and Volume in Units) (2023-2030) 7.1. Asia Pacific Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 7.2. Asia Pacific Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 7.3. Asia Pacific Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 7.4. Asia Pacific Advanced Therapy Medicinal Products Market Size and Forecast, by Country (2023-2030) 7.4.1. China 7.4.1.1. China Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 7.4.1.2. China Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 7.4.1.3. China Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 7.4.2. S Korea 7.4.2.1. S Korea Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 7.4.2.2. S Korea Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 7.4.2.3. S Korea Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 7.4.3. Japan 7.4.3.1. Japan Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 7.4.3.2. Japan Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 7.4.3.3. Japan Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 7.4.4. India 7.4.4.1. India Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 7.4.4.2. India Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 7.4.4.3. India Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 7.4.5. Australia 7.4.5.1. Australia Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 7.4.5.2. Australia Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 7.4.5.3. Australia Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 7.4.6. Indonesia 7.4.6.1. Indonesia Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 7.4.6.2. Indonesia Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 7.4.6.3. Indonesia Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 7.4.7. Malaysia 7.4.7.1. Malaysia Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 7.4.7.2. Malaysia Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 7.4.7.3. Malaysia Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 7.4.8. Vietnam 7.4.8.1. Vietnam Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 7.4.8.2. Vietnam Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 7.4.8.3. Vietnam Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 7.4.9. Taiwan 7.4.9.1. Taiwan Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 7.4.9.2. Taiwan Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 7.4.9.3. Taiwan Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 7.4.10. Rest of Asia Pacific 7.4.10.1. Rest of Asia Pacific Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 7.4.10.2. Rest of Asia Pacific Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 7.4.10.3. Rest of Asia Pacific Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 8. Middle East and Africa Advanced Therapy Medicinal Products Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million and Volume in Units) (2023-2030 8.1. Middle East and Africa Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 8.2. Middle East and Africa Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 8.3. Middle East and Africa Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 8.4. Middle East and Africa Advanced Therapy Medicinal Products Market Size and Forecast, by Country (2023-2030) 8.4.1. South Africa 8.4.1.1. South Africa Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 8.4.1.2. South Africa Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 8.4.1.3. South Africa Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 8.4.2. GCC 8.4.2.1. GCC Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 8.4.2.2. GCC Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 8.4.2.3. GCC Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 8.4.3. Nigeria 8.4.3.1. Nigeria Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 8.4.3.2. Nigeria Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 8.4.3.3. Nigeria Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 8.4.4. Rest of ME&A 8.4.4.1. Rest of ME&A Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 8.4.4.2. Rest of ME&A Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 8.4.4.3. Rest of ME&A Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 9. South America Advanced Therapy Medicinal Products Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million and Volume in Units) (2023-2030 9.1. South America Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 9.2. South America Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 9.3. South America Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 9.4. South America Advanced Therapy Medicinal Products Market Size and Forecast, by Country (2023-2030) 9.4.1. Brazil 9.4.1.1. Brazil Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 9.4.1.2. Brazil Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 9.4.1.3. Brazil Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 9.4.2. Argentina 9.4.2.1. Argentina Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 9.4.2.2. Argentina Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 9.4.2.3. Argentina Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 9.4.3. Rest Of South America 9.4.3.1. Rest Of South America Advanced Therapy Medicinal Products Market Size and Forecast, By Therapy Type (2023-2030) 9.4.3.2. Rest Of South America Advanced Therapy Medicinal Products Market Size and Forecast, By Disease Type (2023-2030) 9.4.3.3. Rest Of South America Advanced Therapy Medicinal Products Market Size and Forecast, By Distribution Channel (2023-2030) 10. Global Advanced Therapy Medicinal Products Market: Competitive Landscape 10.1. MMR Competition Matrix 10.2. Competitive Landscape 10.3. Key Players Benchmarking 10.3.1. Company Name 10.3.2. Service Segment 10.3.3. End-user Segment 10.3.4. Revenue (2023) 10.3.5. Company Locations 10.4. Leading Advanced Therapy Medicinal Products Market Companies, by Market Capitalization 10.5. Market Structure 10.5.1. Market Leaders 10.5.2. Market Followers 10.5.3. Emerging Players 10.6. Mergers and Acquisitions Details 11. Company Profile: Key Players 11.1. Spark Therapeutics, Inc. 11.1.1. Company Overview 11.1.2. Business Portfolio 11.1.3. Financial Overview 11.1.4. SWOT Analysis 11.1.5. Strategic Analysis 11.1.6. Scale of Operation (Small, Medium, and Large) 11.1.7. Details on Partnership 11.1.8. Regulatory Accreditations and Certifications Received by Them 11.1.9. Awards Received by the Firm 11.1.10. Recent Developments 11.2. Bluebird Bio, Inc. 11.3. Novartis AG 11.4. UniQure N.V. 11.5. Celgene Corporation 11.6. Gilead Lifesciences, Inc. 11.7. Kolon TissueGene, Inc. 11.8. JCR Pharmaceuticals Co., Ltd. 11.9. MEDIPOST; 11.10. Vericel Corporation; 11.11. PHARMICELL Co., Ltd 11.12. Organogenesis Inc. 11.13. ViaCyte 11.14. Magenta Therapeutics 11.15. ReNeuron 11.16. Promethera Biosciences 11.17. Fate Therapeutics 11.18. Century Therapeutics 12. Key Findings 13. Industry Recommendations 14. Terms and Glossary
